AcroCyte Therapeutics Inc. is revolutionizing precision medicine through R3CE® (Rapid, Reproducible, Rare Cell 3D Expansion)—the world's only technology that successfully cultures CTCs (Circulating Tumor Cells) from blood and creates personalized 3D cell cultures from any tissue specimen in a week. Our breakthrough eliminates the need for traditional cell lines and animal testing, empowering patients to access truly personalized treatments using their own cells. Through our Onco-REAL™ clinical service, we're transforming cancer care with precise, patient-specific solutions.
Company Details
- Employees
- 13
- Address
- Xizhi District, Taipei,taiwan, Province Of China
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.acrocyte.com/
- Keywords
- Precision Medicine.
- HQ
- Taipei
Acrocyte Therapeutics Questions
Acrocyte Therapeutics's website is https://www.acrocyte.com/
Acrocyte Therapeutics's LinkedIn profile is https://tw.linkedin.com/company/acrocyte-therapeutics
Acrocyte Therapeutics has
13 employees.
View email and phone details for 13
employees at Acrocyte Therapeutics.
Acrocyte Therapeutics's industry is
Biotechnology Research
Acrocyte Therapeutics's top competitors are
Meandmine,
Accuragen,
Abcepta,
Oncodna,
Convergent Genomics,
Anivance Ai,
Care,
Cellmax Life,
Precisemab Biotech Co., Ltd.,
Abnova.
Acrocyte Therapeutics's categories are Biotechnology Research
